São Paulo

Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs R&D Partnership Agreement for Development of GLP1 Supplement for Pets

Retrieved on: 
Wednesday, November 8, 2023
Faculty, NYSE, São Paulo, Federal University of Rio Grande do Sul, Obesity, Cat, Université de Montréal Faculty of Veterinary Medicine, Pet, Doctor of Philosophy, Rio, UNESP, APH, Veterinary medicine, MOU, Medical school, Faculty of Medicine, University of Colombo, University of São Paulo, UFRGS, Animal, University, Universidad, Overweight, Better Choice Parking, Pain management, GLP1, Dog, MS, Physiology, Medicine, Pharmacology, Anesthesia

TAMPA, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, and its research partner, Aimia Pet HealthCo Inc. (APH), today announced that APH has signed a memorandum of understanding (MOU) with Dr. Nadia Crosignani for the development of a GLP1 supplement for pets.

Key Points: 
  • TAMPA, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, and its research partner, Aimia Pet HealthCo Inc. (APH), today announced that APH has signed a memorandum of understanding (MOU) with Dr. Nadia Crosignani for the development of a GLP1 supplement for pets.
  • The MOU sets out the basis for Dr. Crosignani to commence research and development of a GLP1 supplement for use in companion animals.
  • In addition, Dr. Crosignani has a post-doctorate degree from UNESP, Faculty of Medicine, researching in the field of pain management.
  • We see the use of the GLP1 supplement as a significant opportunity for the pet health industry and are assembling top tier partners to help Better Choice and our brands, including Halo, become pioneers in this sector,” commented Mike Young, Chairman of the Board for Better Choice.

Mary Kay Ash Foundation℠ Celebrates Five Years Shaping the Future of Cancer Research in Partnership With UT Southwestern Medical Center

Retrieved on: 
Tuesday, November 7, 2023
Cosmetics, Retail, Oncology, Women, Philanthropy, Hospitals, Catalog, Fund Raising, Foundation, Science, Other Philanthropy, Other Science, Consumer, Research, Health, Fashion, Knowledge, University of Texas Southwestern Medical Center, Human, São Paulo, Publication, AUC, Front Row, Multimedia, Mentorship, Partnership, Cancer, Cell biology, University, Woman, Class, Harold, Shanghai Jiao Tong University, Pharmaceutical industry, Nursing, Geriatrics

Hosted at the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, the fellowship is a two-year postdoctoral program sponsored by the Mary Kay Ash Foundation.

Key Points: 
  • Hosted at the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, the fellowship is a two-year postdoctoral program sponsored by the Mary Kay Ash Foundation.
  • View the full release here: https://www.businesswire.com/news/home/20231107256704/en/
    International Postdoctoral Scholars in Cancer Research, Class of 2023.
  • “For more than two decades, the Mary Kay Ash Foundation and UT Southwestern Medical Center have partnered in a continued commitment to find cures for cancers affecting women,” said Michael Lunceford, President, Mary Kay Ash Foundation Board of Directors.
  • “We appreciate Mary Kay Ash Foundation’s continued investment in UT Southwestern Medical Center and the future of cancer research.

Republic Bank Appoints Francis Mitchell as Senior Vice President, Treasurer and Chief Investment Officer

Retrieved on: 
Tuesday, June 6, 2023
University, Senior, FIDE titles, Engineering, Temple University, Republic First Bancorp, Drexel University, Business administration, Toronto-Dominion Bank, Webster Bank, Growth, Bank, São Paulo, Republic Bank, Management, Science, Fran

PHILADELPHIA, June 06, 2023 (GLOBE NEWSWIRE) -- Republic First Bancorp, Inc. (NASDAQ: FRBK) (the “Company”), the parent company of Republic First Bank d/b/a Republic Bank (the "Bank"), today announced the appointment of Francis “Fran” Mitchell as Senior Vice President, Treasurer and Chief Investment Officer, effective June 1, 2023.

Key Points: 
  • PHILADELPHIA, June 06, 2023 (GLOBE NEWSWIRE) -- Republic First Bancorp, Inc. (NASDAQ: FRBK) (the “Company”), the parent company of Republic First Bank d/b/a Republic Bank (the "Bank"), today announced the appointment of Francis “Fran” Mitchell as Senior Vice President, Treasurer and Chief Investment Officer, effective June 1, 2023.
  • Fran brings a wealth of experience and expertise in the banking and finance industry based on his background holding senior positions at several notable financial institutions.
  • He will report to Mike Harrington, Executive Vice President and Chief Financial Officer.
  • Fran’s previous roles span numerous financial institutions, including Bar Harbor Bank, Webster Bank, and Toronto Dominion Bank.

Remark AI solution wins a $6 million 30-month recurring revenue subscription contract to provide Rio De Janeiro police cars with license plate and mobile facial recognition capabilities utilizing Remark's proprietary artificial intelligence solutions

Retrieved on: 
Wednesday, May 31, 2023
Private sector, São Paulo, Facial recognition, Intelligence, Tech, Person, LAS, Police, Safety, Mining

LAS VEGAS, May 31, 2023 /PRNewswire/ -- Remark Holdings, Inc. (Nasdaq: MARK), a leading provider of artificial intelligence solutions, today announced it has won the first phase of a rollout by the Rio De Janeiro police department to equip their existing police car fleet with license plate and facial recognition capabilities. The deployment, scheduled to be completed over the next 120 days, is a 30-month recurring revenue subscription contract valued at over $6 million. The current technical due diligence period, when passed, will immediately grant additional revenue opportunities for Phase 2 and Phase 3.

Key Points: 
  • The deployment, scheduled to be completed over the next 120 days, is a 30-month recurring revenue subscription contract valued at over $6 million.
  • The current technical due diligence period, when passed, will immediately grant additional revenue opportunities for Phase 2 and Phase 3.
  • Remark AI partnered with iProp.Tech, a local Brazilian system integrator to execute and implement the requirements requested by the Rio De Janeiro police department.
  • "We are excited to partner with Remark AI to implement its proprietary artificial intelligence solutions to improve the license plate and mobile facial recognition capabilities requested by the Rio De Janeiro police department," says Eduardo Ventura, CEO of iProp.Tech.

Group of Shareholders Opposes Equifax offer to Acquire Boa Vista

Retrieved on: 
Tuesday, May 2, 2023
Data Analytics, Professional Services, Finance, FIP, Minority, IPO, TMG, Boa, EGM, Element, Novo Mercado, Boa Vista, EBITDA, Acquisition, NanoBusiness Commercialization Association, LP, Letter, São Paulo, ACSP, Security (finance), Equifax

A group of investors of Boa Vista signed a letter delivered to the Board of Directors at the end of February to state that they do not accept the offer of R$ 8 per share to merge Boa Vista with the non-operational Brazilian subsidiary of Equifax.

Key Points: 
  • A group of investors of Boa Vista signed a letter delivered to the Board of Directors at the end of February to state that they do not accept the offer of R$ 8 per share to merge Boa Vista with the non-operational Brazilian subsidiary of Equifax.
  • The implicit multiple in the offer, 8.9x of Boa Vista’s EBITDA, is low, particularly when compared with the 19.3x multiple for Equifax at the time of the offer.
  • In addition to this, Boa Vista has more than R$ 1 billion in net cash and has been consistently growing more rapidly than Equifax, all elements that justify a much higher price, explains the group.
  • At this price, the Minority Shareholders believe that the shareholders are better served by keeping Boa Vista independent.

FELIPE A. MEDEIROS, M.D., PH.D., JOINS BASCOM PALMER EYE INSTITUTE AS VICE CHAIR FOR TRANSLATIONAL RESEARCH

Retrieved on: 
Friday, March 31, 2023
Molecular biology, Glaucoma, Duke University, Kathleen, University, Biochemistry, Ben, Doctor of Philosophy, Oscar, Risk assessment, Duke, Intelligence, UCSD, University of California, San Diego, Research, Medicine, Bascom Palmer Eye Institute, Science, Student, Bascom H. Palmer, Joseph, Leonard M. Miller School of Medicine, Publication, HIV disease progression rates, Patient, Faculty, Diagnosis, Biostatistics, Paratriathlon, FDA, Medeiros, São Paulo, Data science, Pharmaceutical industry, Management, Nursing, Ophthalmology

MIAMI, March 30, 2023 /PRNewswire/ -- Felipe A. Medeiros, M.D., Ph.D., one of the world's leading glaucoma experts, has joined Bascom Palmer Eye Institute and the University of Miami Miller School of Medicine as professor of ophthalmology and vice chair for translational research.

Key Points: 
  • MIAMI, March 30, 2023 /PRNewswire/ -- Felipe A. Medeiros, M.D., Ph.D., one of the world's leading glaucoma experts, has joined Bascom Palmer Eye Institute and the University of Miami Miller School of Medicine as professor of ophthalmology and vice chair for translational research.
  • "Dr. Medeiros brings extraordinary interdisciplinary expertise to our Institute," said Eduardo C. Alfonso, M.D., professor and director of Bascom Palmer Eye Institute and the Kathleen and Stanley J. Glaser Chair in Ophthalmology.
  • He was also vice chair of technology and professor of electrical and computer engineering, biostatistics and bioinformatics at Duke.
  • At Bascom Palmer, Medeiros plans to advance innovative and impactful translational research, support discovery and technological innovation, and attract and develop outstanding students, trainees and faculty researchers.

Local Support. Global Impact. Regions Bank Launches International Subsidiaries Banking Group

Retrieved on: 
Wednesday, March 29, 2023
Banking, Other Professional Services, Professional Services, Finance, International business, China Construction Bank, Barros, Specialization, University, Czech Republic, Engineering, South Korean International Monetary Fund Agreement, 1997, Champaign–Urbana metropolitan area, Multimedia, Public sector banks in India, Regions Financial Corporation, Electronic, Commercial bank, Region, Yonsei University, International Commercial Bank Tanzania, Miami University, Dominican Republic, FDI, Acquisition, Hana Bank, Commerce, Corporation, International law, Consumer, BBVA, Growth, Physics, Bank, São Paulo, BBVA USA, Financial services, Science, Economics, Laerte Coutinho

Regions Bank on Wednesday announced the launch of its International Subsidiaries Banking Group, a dedicated team focused on delivering financial insights and customized banking services to subsidiaries of international corporations operating in the United States.

Key Points: 
  • Regions Bank on Wednesday announced the launch of its International Subsidiaries Banking Group, a dedicated team focused on delivering financial insights and customized banking services to subsidiaries of international corporations operating in the United States.
  • View the full release here: https://www.businesswire.com/news/home/20230329005289/en/
    Regions Bank is announcing the launch of its International Subsidiaries Banking Group, a dedicated team focused on delivering financial insights and customized banking services to subsidiaries of international corporations operating in the United States.
  • Barros leads a group of international banking specialists who will work with Regions’ Commercial and Corporate Banking relationship managers to support business origination and development for U.S.-based subsidiaries.
  • Regions’ International Subsidiaries Banking Group is focused on deepening relationships in sectors including automotive manufacturing, aerospace, petrochemicals and more.

Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers

Retrieved on: 
Wednesday, March 15, 2023
Research, Conference, Histoplasma capsulatum, Mortality, Fungal infection, Pseudallescheria boydii, Voriconazole, São Paulo, Amphotericin B, Immunology, USP, Gordon Research Conferences, Biology, Caspofungin, Fungal keratitis, Micafungin, World Health Organization, Fungus, Fluconazole, Cryptococcosis, OTCQB, Posaconazole, News, University, Pharmaceutical industry, Vaccine, Antibiotics, Mucorales

Extensive in vitro testing of Brilacidin by these research groups against multiple pathogenic human fungi has been completed.

Key Points: 
  • Extensive in vitro testing of Brilacidin by these research groups against multiple pathogenic human fungi has been completed.
  • USP researchers have also shown Brilacidin to be synergistic with caspofungin in different types of fungi.
  • Beyond Brilacidin’s broad-spectrum ability to directly inhibit fungal pathogens, Brilacidin may favorably modulate the host response to fungal infections.
  • Corresponding posters for these conferences are available on the Events and Presentations section of the Company’s website at the link below.

OnKure Therapeutics Appoints Robbie Alton, Pharm., as Vice President of Clinical Operations

Retrieved on: 
Tuesday, December 6, 2022
Levy Mwanawasa Medical University, Drug discovery, Entrepreneurship, Nautilus, Biochemistry, Halozyme, São Paulo, Cancer, HDAC, NDA, Pharming, History, IND, University, Head, Pharmaceutical industry, Pharmacy

BOULDER, Colo., Dec. 06, 2022 (GLOBE NEWSWIRE) -- OnKure, Inc., a clinical-stage biopharmaceutical company discovering and developing the next generation of oncology precision medicines, today announced the appointment of Roberta (“Robbie”) Alton, Pharm., as Vice President of Clinical Operations.

Key Points: 
  • BOULDER, Colo., Dec. 06, 2022 (GLOBE NEWSWIRE) -- OnKure, Inc., a clinical-stage biopharmaceutical company discovering and developing the next generation of oncology precision medicines, today announced the appointment of Roberta (“Robbie”) Alton, Pharm., as Vice President of Clinical Operations.
  • Robbie has nearly two decades of global clinical development and operations experience across various therapeutic areas, focusing primarily on the oncology space.
  • “We are thrilled to welcome Robbie to OnKure.
  • OnKure is currently developing its lead clinical candidate, OKI-179, an oral, selective Class I HDAC inhibitor, for the treatment of both hematological and solid tumors.

Harness Announces Software Delivery Superheroes, a Global Community of Innovative Technology Experts

Retrieved on: 
Wednesday, November 16, 2022
Hotel manager, ViacomCBS Streaming, Automation, Harness, National Australia Bank, SRE, CBS, TV Guide, Infosys, São Paulo, Big Fish Games, Organization, Apple, IBM, DevOps, UBank, Multimedia, Melbourne, Program, Publishing, PayPal, GameHouse, Yum, NAB, Walmart, Superhero, Enterprise architecture, Booking.com, Zynga, Engineering, Machine learning, Knowledge Based Software Assistant, CNET, Language, Netflix, Video game, Online shopping, Kubernetes, United Airlines, Sénac, Technology

SAN FRANCISCO, Nov. 16, 2022 /PRNewswire/ -- Harness, the Modern Software Delivery Platform company™, today at the {unscripted} conference, announced Software Delivery Superheroes, a new program to showcase the work of a global cohort of software delivery pioneers and innovative Harness customers. These Superheroes spearhead software deployment automation at their organizations, and their software delivery and technical knowledge-sharing – from insights to challenges to best practices – have a substantial impact on the broader community.

Key Points: 
  • Brands
    SAN FRANCISCO, Nov. 16, 2022 /PRNewswire/ -- Harness , the Modern Software Delivery Platform company, today at the {unscripted} conference, announced Software Delivery Superheroes , a new program to showcase the work of a global cohort of software delivery pioneers and innovative Harness customers.
  • These Superheroes spearhead software deployment automation at their organizations, and their software delivery and technical knowledge-sharing from insights to challenges to best practices have a substantial impact on the broader community.
  • With over 17 million deployments and counting, customer adoption is accelerating on the Harness Software Delivery Platform, while Harness continues to expand its technology to include advanced tools and features.
  • Harness, the Modern Software Delivery Platform company, provides a simple, safe and secure way for engineering and DevOps teams to rapidly release applications into production.